These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8834436)

  • 1. Validating the St. Hans rating scale with the abnormal involuntary movement scale (AIMS) in the assessment of tardive dyskinesia.
    Ringo DL; Half LM; Faustman WO
    J Clin Psychopharmacol; 1996 Feb; 16(1):94-5. PubMed ID: 8834436
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): cross-scale comparison in assessing tardive dyskinesia.
    Gharabawi GM; Bossie CA; Lasser RA; Turkoz I; Rodriguez S; Chouinard G
    Schizophr Res; 2005 Sep; 77(2-3):119-28. PubMed ID: 15913963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital movement analysis, a new objective method of measuring tardive dyskinesia and drug-induced parkinsonian tremor: acceptability, reliability and validity.
    Nilsson FM; Hansen BL; Buchel C; Gattaz WF; Gerlach J
    Eur Arch Psychiatry Clin Neurosci; 1996; 246(2):71-7. PubMed ID: 9063911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tardive dyskinesia in schizophrenia. Relationship to minor physical anomalies, frontal lobe dysfunction and cerebral structure on magnetic resonance imaging.
    Waddington JL; O'Callaghan E; Buckley P; Madigan C; Redmond O; Stack JP; Kinsella A; Larkin C; Ennis JT
    Br J Psychiatry; 1995 Jul; 167(1):41-4. PubMed ID: 7551606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for tardive dyskinesia.
    Munetz MR; Schulz SC
    J Clin Psychiatry; 1986 Feb; 47(2):75-7. PubMed ID: 2867994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical trial of nifedipine in schizophrenia and tardive dyskinesia.
    Suddath RL; Straw GM; Freed WJ; Bigelow LB; Kirch DG; Wyatt RJ
    Pharmacol Biochem Behav; 1991 Jul; 39(3):743-5. PubMed ID: 1686106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does tardive dysmentia really exist?
    Lavania S; Praharaj SK; Bains HS; Kumar S; Rathore DM; Mohanty S; Nayak M
    J Neuropsychiatry Clin Neurosci; 2013; 25(1):58-62. PubMed ID: 23487194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity.
    Gerlach J; Korsgaard S; Clemmesen P; Lauersen AM; Magelund G; Noring U; Povlsen UJ; Bech P; Casey DE
    Acta Psychiatr Scand; 1993 Apr; 87(4):244-52. PubMed ID: 8098178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA; Mythily ; Lum A; Huak CY; Kane J
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic investigation of tardive dyskinesia in inpatients.
    Smith JM; Kucharski LT; Oswald WT; Waterman LJ
    Am J Psychiatry; 1979 Jul; 136(7):918-22. PubMed ID: 453354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a six-week drug holiday on symptom status, relapse, and tardive dyskinesia in chronic schizophrenics.
    Shenoy RS; Sadler AG; Goldberg SC; Hamer RM; Ross B
    J Clin Psychopharmacol; 1981 May; 1(3):141-5. PubMed ID: 6117584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association study indicates a protective role of phosphatidylinositol-4-phosphate-5-kinase against tardive dyskinesia.
    Fedorenko OY; Loonen AJ; Lang F; Toshchakova VA; Boyarko EG; Semke AV; Bokhan NA; Govorin NV; Aftanas LI; Ivanova SA
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment in patients with tardive dyskinesia.
    Myslobodsky MS; Tomer R; Holden T; Kempler S; Sigal M
    J Nerv Ment Dis; 1985 Mar; 173(3):156-60. PubMed ID: 3973576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tardive dyskinesia. AIMS (Abnormal Involuntary Movement Scale) as a diagnostic and research tool].
    Burti L; Parolin A; Zanotelli R
    Minerva Med; 1981 Oct; 72(42):2829-36. PubMed ID: 7312199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative symptoms, cognitive dysfunction, tardive akathisia and tardive dyskinesia.
    Sachdev P; Hume F; Toohey P; Doutney C
    Acta Psychiatr Scand; 1996 Jun; 93(6):451-9. PubMed ID: 8831862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of tardive dyskinesia in psychiatric outpatients using a standardized rating scale.
    Rey JM; Hunt GE; Johnson GF
    Aust N Z J Psychiatry; 1981 Mar; 15(1):33-7. PubMed ID: 6973337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis.
    Miller DD; Eudicone JM; Pikalov A; Kim E
    J Clin Psychiatry; 2007 Dec; 68(12):1901-6. PubMed ID: 18162021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An assessment of tardive dyskinesia in schizophrenic outpatients.
    Smith JM; Kucharski LT; Eblen C; Knutsen E; Linn C
    Psychopharmacology (Berl); 1979 Jun; 64(1):99-104. PubMed ID: 113841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.